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Hematogenous Hexamitiasis in a Macaque Monkey with
an Immunodeficiency fiyndrome
COLLEAGUES - Protozoans of the Hexamita species are com-
mon gastrointestinal parasites of poultry, mice, rats, and
hamsters [1] and have been reported as occasional gastrointes-
tinal parasites in nonhuman primates [2]. We have observed the
first case of hematogenous hexamitiasis in a primate. It oc-
curred as an opportunistic infection in a rhesus monkey with
the macaque immunodeficiency syndrome. An ll-month-old
M mulatta was observed to have diffuse lymphadenopathy. At
that time serum-chemistry showed elevated liver-function tests;
hematologic studies showed a leukocyte count of 1.4 x 103 /
mm3 with a differential of 26070 neutrophils, 32% lymphocytes,
22% monocytes, and 20% large, atypical mononuclear cells
with vacuolated cytoplasm and prominent nucleoli. Flagellated
parasites with the morphological appearance of Hexamita
organisms were seen at a frequency of 6-8 per high-power field
on the peripheral blood smear. Although a course of treatment
with metronidazole substantially decreased this hematogenous
protozoal burden, the animal died two weeks later of an over-
whelming bacterial pneumonia. At necropsy all examined
lymph nodes had an absence of follicles, marked lymphocytic
depletion, and extensive histiocytosis. The stroma of the nodes
had a hyalinized appearance, and blood vessels were prominent.
This macaque showed evidence of a process (similar to ac-
quired immune deficiency syndrome) that we have recently ob-
served in macaque monkeys housed at the New England Re-
gional Primate Research Center [3]. Monkeys with this immu-
nodeficiency syndrome have died of unusual opportunistic
infections and tumors. Dramatically diminished responses of
peripheral-blood lymphocytes to lectins and antigens have been
noted in these animals. The hematologic abnormalities seen in
Figure 1. Two Hexamita species organisms in a routine
peripheral blood smear (Wright-Giemsa stain) of a
Macaca mulatta x2,000.
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the present case - that is, neutropenia, monocytosis, and the
presence of an atypical circulating mononuclear cell with
prominent nucleoli and vacuolated cytoplasm - are characteris-
tic findings in this syndrome. Hepatitis and histological evi-
dence of both histiocytosis and a dramatic depletion of normal
cellular elements in lymph nodes are also common in affected
macaques.
Opportunistic infections strikingly similar to those described
in humans with acquired immune deficiency syndrome have
been seen in these immunodeficient macaques. The infectious
agents have included Candida albicans, Pneumocystis carinii,
Mycobacterium avium-M intracellulare, and cytomegalovirus.
The unusual form of protozoal infection that we describe here
illustrates the remarkable diversity of infections that can occur
in the immunocompromised host.
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Acquired Immune Deficiency Syndrome: Is
Disseminated Aspergillosis Predictive of
Underlying Cellular Immune Deficiency?
To THE EDITOR - I read with interest the summary by Dr.
Jaffe et al. [1] of the epidemiological features of the first 1,000
cases of acquired immune deficiency syndrome (AIDS) re-
ported from the United States. In their case definition they state
that disseminated aspergillosis is at least moderately suggestive
of underlying cellular immune deficiency and is thus a marker-
infection for the diagnosis of AIDS. However, this view of the
Correspondence
role of T cell-dependent immunity in aspergillosis is not sup-
ported by the published literature.
Clinical observations suggest that neutropenia [2, 3], immu-
nosuppression with corticosteroids [2, 4, 5], and chronic child-
hood granulomatous disease [6] are the main risk factors for
disseminated aspergillosis. The protective role of the neutrophil
in resistance to the invasive hyphae in the absence of specific
immune mechanisms has been well characterized experimental-
ly both in vitro [7, 8] and in vivo [8]. Cortisone has been shown
to both suppress the unspecific phagocytic resistance to Asper-
gillus organisms provided by alveolar macrophages and neu-
trophils and affect normal and athymic mice alike [8]. Thus,
the fact that steroids render patients susceptible to aspergillosis
cannot be taken as evidence for a role of T cell-mediated im-
munity in aspergillosis. Finally, there are no experimental data
supporting a role for T lymphocytes in immunity to aspergil-
losis [9].
While disseminated or extensively invasive aspergillosis is ex-
tremely rare in normal healthy people and is therefore given
minor consideration in epidemiological studies of AIDS, the
seemingly unjustified statement that aspergillosis is predictive
of a cellular immune deficiency might have an important im-
pact on the general understanding of fungal immunology and
on the evaluation of immune deficiencies other than deficient
cell-mediated immunity in individual patients with AIDS.
In the absence of clinical or experimental data suggesting a
connection between aspergillosis and deficient T cell-mediated
immunity, the following questions occur regarding a possible
correlation between AIDS and aspergillosis: (1) what is the fre-
quency in AIDS of proven infection with this ubiquitous
organism, (2) has aspergillosis been observed as an early
manifestation of AIDS or only as a late complication after
multiple infections or malignancy in severely debilitated
patients, (3) is there any evidence either of neutropenia or of
extensive pulmonary damage that might possibly interfere with
resistance provided by macrophages in these patients, and (4)
has the antifungal activity of the two phagocytic cell lines in-
volved in protection against aspergillus infection been studied
in patients with both AIDS and aspergillosis. Until these ques-
tions are answered it would be advisable to avoid imputing a
link between aspergillosis and T cell-mediated immunity and to
continue to consider this mycosis as indicative of defective un-
specific phagocytic resistance.
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Reply
To THE EDITOR - We thank Dr. Schaffner for his very infor-
mative letter. Of 1,762 AIDS case reports we have analyzed,
only three included disseminated aspergillosis as a diagnosis.
One of these patients also had pneumocystis pneumonia; the
other two patients did not have any other clinical features sug-
gestive of AIDS. Results of T cell studies were not reported for
any of these patients.
In view of the lack of aspergillus infections among reported
AIDS patients and the comments of Dr. Schaffner - and of Dr.
Louise Hawley, who wrote to us directly - we have deleted
aspergillosis from the list of infections considered at least
moderately predictive of AIDS.
HAROLD W. JAFFE, RICHARD M. SELIK
AIDS Activity, Center for Infectious Diseases,
Centers for Disease Control, Atlanta, Georgia
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Endemic Chickenpox Infection on a Cancer Ward
To ThE EDITOR - Second episodes of varicella after a definite
primary exposure to chickenpox are well known in immuno-
suppressed children. We here report an endemic outbreak in
adult patients with cancer. The onset of one part of the endemia
was a widespread herpes-zoster infection in the left cervical
dermatome (located at the C 3, C 4, and C 5 vertebrae) of pa-
tient 1, a 50-year-old man being treated for Hodgkin's disease.
Concurrently residing in the same room was patient 2, a 25-
year-old man receiving chemotherapy for abdominal liposar-
coma, who had no history of the disease but developed typical
chickenpox 21 days later, after having been discharged. The
course of his disease was complicated by varicella-related pneu-
monitis with bilateral "fluffy" nodular infiltrations (as indicated
